Newer insulin may reduce low blood sugar in youth with type 1 diabetes

A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogs in low-resource settings.